Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
12.2M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
743K
-
Shares change
-
+5.03K
-
Total reported value, excl. options
-
$5.01M
-
Value change
-
+$30.9K
-
Number of buys
-
8
-
Number of sells
-
-7
-
Price
-
$6.74
Significant Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) as of Q3 2023
30 filings reported holding CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share as of Q3 2023.
Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 743K shares
of 12.2M outstanding shares and own 6.1% of the company stock.
Largest 10 shareholders include Ikarian Capital, LLC (196K shares), VANGUARD GROUP INC (179K shares), Sio Capital Management, LLC (150K shares), BlackRock Inc. (81.2K shares), BOOTHBAY FUND MANAGEMENT, LLC (41.6K shares), GEODE CAPITAL MANAGEMENT, LLC (37.2K shares), DIMENSIONAL FUND ADVISORS LP (29.2K shares), STATE STREET CORP (13.2K shares), FMR LLC (3.35K shares), and MORGAN STANLEY (3.29K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.